U.S. markets open in 1 hour 27 minutes

Cerner Corporation (CERN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
72.86+0.56 (+0.77%)
At close: 04:00PM EST
72.39 -0.47 (-0.65%)
Pre-Market: 07:36AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close72.30
Bid70.07 x 1000
Ask72.95 x 800
Day's Range71.86 - 73.33
52 Week Range67.96 - 84.20
Avg. Volume2,229,566
Market Cap21.437B
Beta (5Y Monthly)0.73
PE Ratio (TTM)42.86
Earnings DateN/A
Forward Dividend & Yield0.88 (1.20%)
Ex-Dividend DateSep 24, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-17% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CERN

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cerner Corporation
    Analyst Report: Cerner Corp.Based in Kansas City, Missouri, Cerner provides a range of information software products, professional services, and medical device integration and remote hosting services for healthcare providers at more than 27,000 facilities worldwide. The company is a component of the S&P 500 and employs roughly 26,400 people.
    Fair Value
    Economic Moat
    12 days agoArgus Research
View more
  • GlobeNewswire

    Cerner Names Nasim Afsar, MD MBA as Company’s First Chief Health Officer

    Experienced Clinical Executive to Lead Patient and Caregiver ExperiencesKANSAS CITY, Mo., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (NASDAQ: CERN), a global healthcare technology company, today announced Nasim Afsar, MD, MBA, MHM, as the company’s first Chief Health Officer, effective January 2022. In this new role, Dr. Afsar will lead Cerner’s more than 1,000 healthcare professionals who provide insight and guidance to product development and improving the lives of patients and careg

  • PR Newswire

    Transplant Connect and Cerner streamline organ donation and transplant process

    Transplant Connect, a Los Angeles-based medical software company that has introduced innovative new technology known as iReferralSM, and Cerner Corporation, a global healthcare technology company, announce their new collaboration to enable automated donor referrals. This new technology is designed to help increase and expedite potential organ, tissue and eye donor referrals to increase recipient matches, lessen missed opportunities for timely donation and reduce the number of hours caregivers sp

  • GlobeNewswire

    Cerner Reports Third Quarter 2021 Results

    Delivers Strong Results Across Key MetricsGAAP Operating Margin and Diluted EPS Lower; Adjusted Operating Margin and Adjusted Diluted EPS Both up Sharply vs. Year-Ago QuarterFull-Year Guidance Increased KANSAS CITY, Mo., Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021. The third quarter 2021 earnings release can be viewed here as well as on the company’s website at